ALK gene rearrangements have been described in 3–5% of lung adenocarcinomas (ADC), and the presence of dysregulated ALK has been described in at least 18 cancer types (reviewed in 1). Since lung cancer is a common type of cancer, an estimated 70,000 cases of non-small cell lung cancer (NSCLC) which have ALK genomic alterations occur… Read article →
Anaplastic lymphoma kinase (ALK) gene rearrangements are found in 3–5% of lung adenocarcinomas (ADC) (2–4, Figure 1), and over 20 ALK fusion partners have been implicated in non-small-cell lung cancer (NSCLC) (5). Thanks to the relatively recent development of small molecule targeted therapies, the ALK oncogene is now targetable using ALK tyrosine kinase inhibitors (TKIs)… Read article →
Want to have your testimonial about #AmniSure recorded? Visit us and our great videographers at booth 505 @ #AWHONN2017, Last chance to win a prize - stop by our booth 505 at #AWHONN2017 and get a road map stamp! https://t.co/DwvYSaK03V, We offer free monthly #CNE webinars on topics in #HighRiskPregnancy - let us tell you about it at booth 505 @… https://t.co/smXM4yg3RX, Hey, we have a little something for you - come get your free cake pop at our booth 505 @ #AWHONN2017 https://t.co/pU8kt4VvKG, We're at booth 505 to talk to you about #AmniSure - want to know more? We're happy to welcome you #AWHONN2017 https://t.co/sMCdkeyJuR, 